Related Experiment Videos
Pilot projects to stimulate adverse drug reaction reporting
Journal of Clinical Pharmacy and Therapeutics
|August 1, 1987
Summary
This study outlines strategies to encourage adverse drug reporting, highlighting the new Mississippi Adverse Drug Reaction Reporting Programme. Effective reporting systems are crucial for patient safety and drug monitoring.
Area of Science:
- Pharmacovigilance
- Public Health
Background:
- Adverse drug reactions (ADRs) pose a significant public health risk.
- Effective monitoring systems are essential for identifying and mitigating ADRs.
Purpose of the Study:
- To describe schemes for stimulating adverse drug reporting.
- To emphasize the Mississippi Adverse Drug Reaction Reporting Programme.
Main Methods:
- Review of existing adverse drug reporting schemes.
- Description of the operational framework of the Mississippi ADR Reporting Programme.
Main Results:
- Various strategies can enhance the reporting of adverse drug events.
- The Mississippi program represents a recent initiative to improve ADR data collection.
Conclusions:
- Stimulating adverse drug reporting is vital for pharmacovigilance.
- The Mississippi Adverse Drug Reaction Reporting Programme offers a model for enhancing drug safety surveillance.